Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$38.7M
-19.0% from 2023
Prescriptions
1.8M
$21.92 per claim
Patients
971K
220,731 prescribers
Total spending, 2024
$38.7M
$39.82 per patient
Medicare prescription drug plans paid $38.7M for Clotrimazole-Betamethasone in 2024, for 1,764,413 prescriptions and refills to 971,380 patients (down 19.0% from 2023). The average cost per claim was $21.92.
Florida had the highest Medicare cost for Clotrimazole-Betamethasone in 2024: $5.1M for 257,223 claims, followed by Puerto Rico ($4.5M).
Gregory Rivera, podiatry in New York, NY, had the highest Medicare cost for Clotrimazole-Betamethasone in 2024: 1,860 claims costing $58K.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Gregory Rivera New York, NY | Podiatry | 1,860 | 437 | $58K |
| Norris Morrison Sr. Apple Valley, CA | Podiatry | 486 | 146 | $26K |
| Douglas E Campbell |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 205,696 | 1,598,558 | 879,153 | $48.3M |
| 2023 | 212,368 | 1,657,717 | 919,082 | $47.8M |
| 2024 | 220,731 | 1,764,413 | 971,380 | $38.7M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Podiatry |
| 901 |
| 326 |
| $26K |
| Ting T Zhang Flushing, NY | Podiatry | 1,178 | 259 | $25K |
| Edwin Valentin Bayamon, PR | Family Practice | 793 | 417 | $24K |
| 1427279884 | General Practice | 409 | 138 | $22K |
| Rafael Soto Toa Baja, PR | General Practice | 451 | 139 | $18K |
| Yokaira A Espiritusanto Passaic, NJ | Podiatry | 456 | 150 | $17K |
| Antonio R Olivencia-Echeandia Mayaguez, PR | General Practice | 465 | 136 | $17K |
| Drore Eisen Cincinnati, OH | Dermatology | 777 | 433 | $16K |
| Shing C Yuen Elmhurst, NY | Podiatry | 709 | 370 | $16K |
| Mario Maldonado Ramirez Corozal, PR | Internal Medicine | 433 | 148 | $15K |
| Jose A Torres San Lorenzo, PR | General Practice | 364 | 114 | $14K |
| Francisco J Rivera Comerio, PR | General Practice | 411 | 115 | $14K |
| Kelvin Gonzalez Soto Moca, PR | General Practice | 405 | 138 | $14K |
| Kavitha Rajan Houston, TX | Internal Medicine | 17 | Under 11 | $14K |
| Natalia Maximovsky Staten Island, NY | Nurse Practitioner | 631 | 120 | $13K |
| Juan C Ramos Martinez San Juan, PR | General Practice | 255 | 92 | $13K |
| Jose A Morales Guayama, PR | General Practice | 415 | 198 | $13K |
| Tim Ioannides Port Saint Lucie, FL | Dermatology | 532 | 311 | $13K |
| Pedro D Santiago Humacao, PR | Internal Medicine | 379 | 109 | $12K |
| Humberto N Olivencia Mayaguez, PR | Internal Medicine | 335 | 90 | $12K |
| Erasto Rodriguez Cidra, PR | Internal Medicine | 366 | 111 | $12K |
| Abdul Wahid Brooklyn, NY | Internal Medicine | 566 | 113 | $12K |
| Lionel Velez Montijo Bayamon, PR | Internal Medicine | 323 | 115 | $12K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Taro Pharm USA | 643,952 | $16.2M |
| Fougera/Sandoz SDZ.SW | 568,750 | $10.9M |
| Actavis/Teva TEVA | 264,333 | $5.6M |
| Northstar Rx Ll | 269,797 | $5.5M |
| Glenmark Pharma GLENMARK.NS | 18,167 | $489K |